Xphos, min 97%, 1 g, emballage verre

Benzamide, 95%, 100g

Methyl 2-(1,3-dioxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl)acetate, 97%, 2g

Amyl 4-Hydroxybenzoate>98.0%(GC)(T)25g

6,6-Difluoro-3-azabicyclo[3.1.0]hexane oxalate(2:1), 95.0%, 10g

4-Bromoantipyrine>98.0%(HPLC)(T)5g

ethyl 8-(3,4-dimethoxyphenyl)-8-oxooctanoate, 97.0%, 2g

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 97.0%, 250mg

3,4-Dichlorophenylalanine, 95.0%, 250mg

Benzo[b]thiophen-3-ylmethanamine, 95.0%, 10g

(prop-2-en-1-yl)[(3,4,5-trimethoxyphenyl)methyl]amine, 95.0%, 10g

1-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole hydrochloride, 95.0%, 1g

Methyl 5-bromobenzo[d]isoxazole-3-carboxylate, 96%, 100mg